Drug allergy de-labelling in the clinical setting: an all hands on deck opportunity

Drug allergy de-labelling is when a listed drug is removed from the allergy section. In an ideal scenario, this is then communicated in a streamlined process to the patient and their healthcare settings. The future of large-scale drug allergy de-labelling rests in multiple arenas: culture shifts, easily adapted tools to de-label our largest drug allergy categories, and electronic health record (EHR) cross-talk. The present functionalities of most EHR allergy sections and ignorance of their content, are at odds with our universal goals of providing highly reliable, expert, safe, affordable care.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Perspective Source Type: research